Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9913)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 27, 2014 (publication date) through May 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ashworth RE, Wu J. Mammalian target of rapamycin inhibition in hepatocellular carcinoma. World J Hepatol 2014; 6(11): 776-782 [PMID: 25429315 DOI: 10.4254/wjh.v6.i11.776] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i11/776.htm |
| Number | Citing Articles |
| 1 |
Susanne Schuster, Melanie Penke, Theresa Gorski, Rolf Gebhardt, Thomas S. Weiss, Wieland Kiess, Antje Garten. FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells. Biochemical and Biophysical Research Communications 2015; 458(2): 334 doi: 10.1016/j.bbrc.2015.01.111
|
| 2 |
Chiao-Fang Teng, Han-Chieh Wu, Woei-Cherng Shyu, Long-Bin Jeng, Ih-Jen Su. Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma. Cell Transplantation 2017; 26(3): 429 doi: 10.3727/096368916X694382
|
| 3 |
Aly O. Aboelfotoh, Enas M. Foda, Ahmed M. Elghandour, Nahla M. Teama, Reham A. Abouzein, Ghada A. Mohamed. Talin-1; other than a potential marker for hepatocellular carcinoma diagnosis. Arab Journal of Gastroenterology 2020; 21(2): 80 doi: 10.1016/j.ajg.2020.04.017
|
| 4 |
Ayse Erdogan, Aysun Ozkan. Cetuximab and epirubicin HCl-combined application as a possibility to treat both parental and epirubicin HCl-resistant liver cancer cells. Biologia Futura 2019; 70(3): 175 doi: 10.1556/019.70.2019.22
|
| 5 |
Liang-Jun Yan, Zhiyou Cai. Molecules to Medicine with mTOR. 2016; : 365 doi: 10.1016/B978-0-12-802733-2.00009-8
|
| 6 |
Alexander Kotlyar, Hugh S. Taylor, Thomas M. D'Hooghe. Use of immunomodulators to treat endometriosis. Best Practice & Research Clinical Obstetrics & Gynaecology 2019; 60: 56 doi: 10.1016/j.bpobgyn.2019.06.006
|
| 7 |
Andreas Kroh, Jeanette Walter, Herdit Schüler, Jochen Nolting, Roman Eickhoff, Daniel Heise, Ulf Peter Neumann, Thorsten Cramer, Tom Florian Ulmer, Athanassios Fragoulis. A Newly Established Murine Cell Line as a Model for Hepatocellular Cancer in Non-Alcoholic Steatohepatitis. International Journal of Molecular Sciences 2019; 20(22): 5658 doi: 10.3390/ijms20225658
|
| 8 |
Raquel Ordoñez, Anna Fernández, Néstor Prieto‐Domínguez, Laura Martínez, Carmen García‐Ruiz, José C. Fernández‐Checa, José L. Mauriz, Javier González‐Gallego. Ceramide metabolism regulates autophagy and apoptotic cell death induced by melatonin in liver cancer cells. Journal of Pineal Research 2015; 59(2): 178 doi: 10.1111/jpi.12249
|
| 9 |
Daniel da Motta Girardi, Tatiana Strava Correa, Marcela Crosara Teixeira, Gustavo Dos Santos Fernandes. Hepatocellular Carcinoma: Review of Targeted and Immune Therapies. Journal of Gastrointestinal Cancer 2018; 49(3): 227 doi: 10.1007/s12029-018-0121-4
|
| 10 |
Qianwei Ye, Sunbin Ling, Guangjiang Jiang, Qiaonan Shan, Shengjun Xu, Qifan Zhan, Yifeng Wu, Yuchen Liu, Shusen Zheng, Xiao Xu. Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria. European Journal of Surgical Oncology 2021; 47(10): 2533 doi: 10.1016/j.ejso.2021.04.001
|
| 11 |
Kai Hu, Hai-Bo Dai, Zhi-Long Qiu. mTOR signaling in osteosarcoma: Oncogenesis and therapeutic aspects (Review). Oncology Reports 2016; 36(3): 1219 doi: 10.3892/or.2016.4922
|
| 12 |
Jianjun Lu, You Pan, Xin Xia, Yong Gu, Yiyan Lei. Prognostic Significance of mTOR and PTEN in Patients with Esophageal Squamous Cell Carcinoma. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/417210
|
| 13 |
Zichen Xie, Jiqin Wang, Mei Liu, Deshan Chen, Chao Qiu, Keyu Sun, Cong Cao. CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo. PLOS ONE 2017; 12(3): e0173252 doi: 10.1371/journal.pone.0173252
|
| 14 |
Gang Yin, Jin Fan, Wei Zhou, Qingfeng Ding, Jun Zhang, Xuan Wu, Pengyu Tang, Hao Zhou, Bowen Wan, Guoyong Yin. ERK inhibition sensitizes CZ415-induced anti-osteosarcoma activityin vitroandin vivo. Oncotarget 2017; 8(47): 82027 doi: 10.18632/oncotarget.18303
|
| 15 |
Kwang-Woong Lee, Seong Hoon Kim, Kyung Chul Yoon, Jeong-Moo Lee, Jae-Hyung Cho, Suk Kyun Hong, Nam-Joon Yi, Sung-Sik Han, Sang-Jae Park, Kyung-Suk Suh. Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial. Journal of Clinical Medicine 2020; 9(10): 3264 doi: 10.3390/jcm9103264
|
| 16 |
Kangjian Song, Fu He, Yang Xin, Ge Guan, Junyu Huo, Qingwei Zhu, Ning Fan, Yuan Guo, Yunjin Zang, Liqun Wu. TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy. Pharmacogenomics and Personalized Medicine 2021; : 269 doi: 10.2147/PGPM.S294307
|
| 17 |
Giuseppe Tridente. Adverse Events and Oncotargeted Kinase Inhibitors. 2017; : 167 doi: 10.1016/B978-0-12-809400-6.00008-1
|
| 18 |
Wei Liao, Wanren Yang, Jiecheng Xu, Zhengming Yan, Mingxin Pan, Xiaoping Xu, Shuqin Zhou, Yu Zhu, Jianqiang Lan, Min Zeng, Xu Han, Shao Li, Yang Li, Kangyan Liang, Yi Gao, Qing Peng. Therapeutic Potential of CUDC-907 (Fimepinostat) for Hepatocarcinoma Treatment Revealed by Tumor Spheroids-Based Drug Screening. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.658197
|
| 19 |
Patrizia Burra, Kryssia I Rodriguez-Castro. Neoplastic disease after liver transplantation: Focus on <italic>de novo</italic> neoplasms. World Journal of Gastroenterology 2015; 21(29): 8753-8768 doi: 10.3748/wjg.v21.i29.8753
|
| 20 |
Mehmet A. Kisacam, Pinar Ambarcioglu, Akin Yakan. Calcium fructoborate regulate colon cancer (Caco‐2) cytotoxicity through modulation of apoptosis. Journal of Biochemical and Molecular Toxicology 2022; 36(5) doi: 10.1002/jbt.23021
|
| 21 |
Lin Xu, Chenyan Yang, Jing Wang, Zun Li, Rong Huang, Honghui Ma, Jie Ma, Qingzhi Wang, Xiwen Xiong. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice. Biochemical and Biophysical Research Communications 2021; 578: 142 doi: 10.1016/j.bbrc.2021.09.036
|
| 22 |
D. Koeberle, J.-F. Dufour, G. Demeter, Q. Li, K. Ribi, P. Samaras, P. Saletti, A.D. Roth, D. Horber, M. Buehlmann, A.D. Wagner, M. Montemurro, G. Lakatos, J. Feilchenfeldt, M. Peck-Radosavljevic, D. Rauch, B. Tschanz, G. Bodoky. Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Annals of Oncology 2016; 27(5): 856 doi: 10.1093/annonc/mdw054
|
| 23 |
Faiza Ahmed, Faiza Zakaria, Godsgift Enebong Nya, Mohamad Mouchli. Sirolimus <i>vs</i> tacrolimus: Which one is the best therapeutic option for patients undergoing liver transplantation for hepatocellular carcinoma?. World Journal of Gastrointestinal Surgery 2022; 14(8): 862-866 doi: 10.4240/wjgs.v14.i8.862
|
| 24 |
XU REN, YIFENG WANG, GANG XU, LIBING DAI. Effect of rapamycin on endometriosis in mice. Experimental and Therapeutic Medicine 2016; 12(1): 101 doi: 10.3892/etm.2016.3280
|
| 25 |
Fang Huang, Bing-Rong Wang, Yi-Gang Wang. Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(41): 4643-4651 doi: 10.3748/wjg.v24.i41.4643
|
| 26 |
Dàlia Raïch-Regué, Kellsye P. Fabian, Alicia R. Watson, Ronald J. Fecek, Walter J. Storkus, Angus W. Thomson. Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8+ effector T cell responses. OncoImmunology 2016; 5(6): e1146841 doi: 10.1080/2162402X.2016.1146841
|
| 27 |
Lars Fransecky, Liliana H Mochmann, Claudia D Baldus. Outlook on PI3K/AKT/mTOR inhibition in acute leukemia. Molecular and Cellular Therapies 2015; 3(1) doi: 10.1186/s40591-015-0040-8
|
| 28 |
Jonathan T. Busada, Bryan A. Niedenberger, Ellen K. Velte, Brett D. Keiper, Christopher B. Geyer. Mammalian target of rapamycin complex 1 (mTORC1) Is required for mouse spermatogonial differentiation in vivo. Developmental Biology 2015; 407(1): 90 doi: 10.1016/j.ydbio.2015.08.004
|
| 29 |
Minyue Bao, Kaiwen Zhang, Yangyini Wei, Weihan Hua, Yanzi Gao, Xin Li, Ling Ye. Therapeutic potentials and modulatory mechanisms of fatty acids in bone. Cell Proliferation 2020; 53(2) doi: 10.1111/cpr.12735
|
| 30 |
XIAO ZHANG, YULAN WANG, JIAYI WANG, FENYONG SUN. Protein-protein interactions among signaling pathways may become new therapeutic targets in liver cancer (Review). Oncology Reports 2016; 35(2): 625 doi: 10.3892/or.2015.4464
|
| 31 |
Chunmei Wang, Li Che, Junjie Hu, Shanshan Zhang, Lijie Jiang, Gavinella Latte, Maria I. Demartis, Junyan Tao, Bing Gui, Maria G. Pilo, Silvia Ribback, Frank Dombrowski, Matthias Evert, Diego F. Calvisi, Xin Chen. Activated mutant forms of PIK3CA cooperate with RasV12 or c‐Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade. Liver International 2016; 36(8): 1176 doi: 10.1111/liv.13055
|
| 32 |
Zhenzhen Jin, Huanfu Niu, Xuenan Wang, Lei Zhang, Qin Wang, Aijun Yang. Preclinical study of CC223 as a potential anti-ovarian cancer agent. Oncotarget 2017; 8(35): 58469 doi: 10.18632/oncotarget.17753
|
| 33 |
Tobias Engl, Jochen Rutz, Sebastian Maxeiner, Eva Juengel, Frederik Roos, Wael Khoder, Wolf O. Bechstein, Karen Nelson, Igor Tsaur, Axel Haferkamp, Roman A. Blaheta. mTOR inhibition reduces growth and adhesion of hepatocellular carcinoma cells in vitro. Molecular Medicine Reports 2017; 16(5): 7064 doi: 10.3892/mmr.2017.7401
|
| 34 |
Jun-ying Wang, Xin Jin, Xin Zhang, Xiao-feng Li. CC-223 inhibits human head and neck squamous cell carcinoma cell growth. Biochemical and Biophysical Research Communications 2018; 496(4): 1191 doi: 10.1016/j.bbrc.2018.01.168
|
| 35 |
Wei Zhang, Bingyu Chen, Yu Zhang, Kaiqiang Li, Ke Hao, Luxi Jiang, Ying Wang, Xiaozhou Mou, Xiaodong Xu, Zhen Wang. The anti-hepatocellular carcinoma cell activity by a novel mTOR kinase inhibitor CZ415. Biochemical and Biophysical Research Communications 2017; 487(3): 494 doi: 10.1016/j.bbrc.2017.03.156
|
| 36 |
Poh Seng Tan, Mark D. Muthiah, Tsingyi Koh, Yee Leong Teoh, Albert Chan, Alfred Kow, Qishi Zheng, Choon Hyuck David Kwon, Guan Huei Lee, Cosmas Rinaldi A. Lesmana, Vanessa de Villa, James Fung, Kieron Lim. Asian Liver Transplant Network Clinical Guidelines on Immunosuppression in Liver Transplantation. Transplantation 2019; 103(3): 470 doi: 10.1097/TP.0000000000002532
|
| 37 |
Hong-Gang Kang, Bao-Zhong Wang, Jing Zhang, Mei-Rong Liu, Ying-Xue Li. Combination of temsirolimus and adriamycin exhibits an enhanced antitumor effect in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2017; 41(2): 197 doi: 10.1016/j.clinre.2016.09.005
|
| 38 |
Panpan Wang, Xiaobo Xu, Yinghong Li, Bo Li, Qinglan Pei, Pei Yu, Chenxi Jing, Meng Lu. Discovery of Novel Mammalian target of rapamycin (mTOR) Inhibitors by Support Vector Machine. IOP Conference Series: Earth and Environmental Science 2021; 692(3): 032028 doi: 10.1088/1755-1315/692/3/032028
|
| 39 |
Alicia Bort, Elena Spínola, Nieves Rodríguez-Henche, Inés Díaz-Laviada. Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation. Oncotarget 2017; 8(50): 87684 doi: 10.18632/oncotarget.21196
|
| 40 |
Mehmet Ali Kisacam, Gonca Ozan Kocamuftuoglu, Ibrahim Enver Ozan, Mehmet Yaman, Sema Temizer Ozan. Calcium Fructoborate Prevents Skin Cancer Development in Balb-c Mice. Biological Trace Element Research 2020; 196(1): 131 doi: 10.1007/s12011-019-01897-y
|
| 41 |
Chandramohan Kiruthiga, Kasi Pandima Devi, Seyed M. Nabavi, Anupam Bishayee. Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma. Cancers 2020; 12(3): 562 doi: 10.3390/cancers12030562
|
| 42 |
Giuseppe Tarantino, Paolo Magistri, Roberto Ballarin, Raffaele Di Francia, Massimiliano Berretta, Fabrizio Di Benedetto. Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the Literature. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00387
|
| 43 |
Emerson Y Chen, Charles D Lopez, Gina M Vaccaro. Updates in the Systemic Treatment of Hepatocellular Carcinoma. Oncology & Hematology Review (US) 2018; 14(2): 76 doi: 10.17925/OHR.2018.14.2.76
|
| 44 |
James M. Neuberger, Wolf O. Bechstein, Dirk R.J. Kuypers, Patrizia Burra, Franco Citterio, Sabina De Geest, Christophe Duvoux, Alan G. Jardine, Nassim Kamar, Bernhard K. Krämer, Herold J. Metselaar, Frederik Nevens, Jacques Pirenne, Manuel L. Rodríguez-Perálvarez, Didier Samuel, Stefan Schneeberger, Daniel Serón, Pavel Trunečka, Giuseppe Tisone, Teun van Gelder. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients. Transplantation 2017; 101(4S): S1 doi: 10.1097/TP.0000000000001651
|
| 45 |
Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis. International Journal of Molecular Sciences 2019; 20(18): 4659 doi: 10.3390/ijms20184659
|
| 46 |
CONGREN WANG, XUEJIN WANG, ZIJIAN SU, HONGJIANG FEI, XIAOYU LIU, QUNXIONG PAN. The novel mTOR inhibitor Torin-2 induces autophagy and downregulates the expression of UHRF1 to suppress hepatocarcinoma cell growth. Oncology Reports 2015; 34(4): 1708 doi: 10.3892/or.2015.4146
|
| 47 |
Qingqing Lu, Jie Li, Hui Cao, Chenlu Lv, Xiaolin Wang, Shiqiong Cao. Comparison of diagnostic accuracy of Midkine and AFP for detecting hepatocellular carcinoma: a systematic review and meta-analysis. Bioscience Reports 2020; 40(3) doi: 10.1042/BSR20192424
|
| 48 |
Koji Taniguchi, Shinichiro Yamachika, Feng He, Michael Karin. p62/SQSTM1—Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer. FEBS Letters 2016; 590(15): 2375 doi: 10.1002/1873-3468.12301
|
| 49 |
Mahmoud A. Younis, Ikramy A. Khalil, Mahmoud M. Abd Elwakil, Hideyoshi Harashima. A Multifunctional Lipid-Based Nanodevice for the Highly Specific Codelivery of Sorafenib and Midkine siRNA to Hepatic Cancer Cells. Molecular Pharmaceutics 2019; 16(9): 4031 doi: 10.1021/acs.molpharmaceut.9b00738
|
| 50 |
Bing Han, Yi-Qun Yu, Qi-Lian Yang, Chun-Ying Shen, Xiao-Juan Wang. Kaempferol induces autophagic cell death of hepatocellular carcinoma cells via activating AMPK signaling. Oncotarget 2017; 8(49): 86227 doi: 10.18632/oncotarget.21043
|